Form 8-K - Current report:
SEC Accession No. 0001655759-25-000103
Filing Date
2025-06-13
Accepted
2025-06-13 07:12:58
Documents
17
Period of Report
2025-06-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20250613.htm   iXBRL 8-K 35166
2 EX-99.1 ehadatarelease61325.htm EX-99.1 11499
6 ehadatarelease61325001.jpg GRAPHIC 215087
7 ehadatarelease61325002.jpg GRAPHIC 221687
8 ehadatarelease61325003.jpg GRAPHIC 260697
9 ehadatarelease61325004.jpg GRAPHIC 95362
  Complete submission text file 0001655759-25-000103.txt   1267417

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20250613.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20250613_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20250613_pre.xml EX-101.PRE 13581
19 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20250613_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 251044735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)